HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer".

AuthorsAntonietta Santoro, Patrizia Gazzerro, Anna Maria Malfitano, Simona Pisanti, Chiara Laezza, Maurizio Bifulco
JournalInternational journal of cancer (Int J Cancer) Vol. 123 Issue 1 Pg. 243-4 (Jul 01 2008) ISSN: 1097-0215 [Electronic] United States
PMID18395892 (Publication Type: Letter, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • Anti-Inflammatory Agents
  • Anti-Obesity Agents
  • Antineoplastic Agents
  • Piperidines
  • Pyrazoles
  • Receptor, Cannabinoid, CB1
  • AM 251
  • Rimonabant
Topics
  • Animals
  • Anti-Inflammatory Agents (administration & dosage, pharmacology)
  • Anti-Obesity Agents (administration & dosage, adverse effects, pharmacology)
  • Antineoplastic Agents (administration & dosage, pharmacology)
  • Carcinoma (chemically induced, prevention & control)
  • Cell Survival (drug effects)
  • Colorectal Neoplasms (chemically induced, prevention & control)
  • Dose-Response Relationship, Drug
  • Humans
  • Mice
  • Obesity (drug therapy)
  • Piperidines (pharmacology)
  • Pyrazoles (pharmacology)
  • Receptor, Cannabinoid, CB1 (antagonists & inhibitors)
  • Rimonabant
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: